Hagen Brett R — SEC insider filings

SEC reporting owner CIK 1681782. 47 insider filings on record with FilingPulse; latest filed 2026-11-12.

Transaction summary — filings shown

Covers all 47 filings on record, filed 2021-01-21 to 2026-11-12. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Kalaris Therapeutics, Inc. (KLRS)Chief Accounting Officer45—56 legs · 118,703 sh · $728,14411
InMed Pharmaceuticals Inc. (MTRI)See Remarks2——1

Insider filings — Hagen Brett R

FiledFormIssuerReported transactionsSource
2026-11-123InMed Pharmaceuticals Inc. (MTRI)Holdings only — no transactions reportedEDGAR
2026-11-124InMed Pharmaceuticals Inc. (MTRI)Grant/award (A): 171,000 (derivative) @ $0EDGAR
2026-03-234Kalaris Therapeutics, Inc. (KLRS)Sale (S): 1,915 @ $6.72 · Grant/award (A): 60,800 (derivative) @ $0EDGAR
2025-04-114Kalaris Therapeutics, Inc. (KLRS)Grant/award (A): 50,262 (derivative) @ $0EDGAR
2025-03-274Kalaris Therapeutics, Inc. (KLRS)Sale (S): 907 @ $8.97EDGAR
2025-02-244Allovir, Inc. (ALVR)Sale (S): 96 @ $10.08EDGAR
2025-01-274Allovir, Inc. (ALVR)Sale (S): 32 @ $9.45 · Sale (S): 4 @ $9.94EDGAR
2025-01-134Allovir, Inc. (ALVR)Sale (S): 332 @ $0.44EDGAR
2024-11-204Allovir, Inc. (ALVR)Sale (S): 554 @ $0.55EDGAR
2024-11-064Allovir, Inc. (ALVR)Sale (S): 1,655 @ $0.86EDGAR
2024-10-234Allovir, Inc. (ALVR)Sale (S): 479 @ $0.78 · Sale (S): 486 @ $0.77EDGAR
2024-10-044Allovir, Inc. (ALVR)Sale (S): 301 @ $0.81EDGAR
2024-08-204Allovir, Inc. (ALVR)Sale (S): 544 @ $0.76EDGAR
2024-08-074Allovir, Inc. (ALVR)Sale (S): 1,692 @ $0.73EDGAR
2024-07-234Allovir, Inc. (ALVR)Sale (S): 479 @ $0.75 · Sale (S): 481 @ $0.74EDGAR
2024-07-034Allovir, Inc. (ALVR)Sale (S): 304 @ $0.72EDGAR
2024-05-214Allovir, Inc. (ALVR)Sale (S): 541 @ $0.75EDGAR
2024-05-074Allovir, Inc. (ALVR)Sale (S): 1,597 @ $0.80EDGAR
2024-04-234Allovir, Inc. (ALVR)Sale (S): 473 @ $0.75 · Sale (S): 480 @ $0.75EDGAR
2024-04-044Allovir, Inc. (ALVR)Sale (S): 281 @ $0.77EDGAR
2024-02-224Allovir, Inc. (ALVR)Sale (S): 494 @ $0.70EDGAR
2024-02-094Allovir, Inc. (ALVR)Sale (S): 11,150 @ $0.67EDGAR
2024-02-064Allovir, Inc. (ALVR)Sale (S): 5,792 @ $0.67EDGAR
2024-01-254Allovir, Inc. (ALVR)Sale (S): 901 @ $0.67EDGAR
2024-01-084Allovir, Inc. (ALVR)Sale (S): 310 @ $0.64EDGAR
2024-01-024Allovir, Inc. (ALVR)Sale (S): 28,335 @ $0.74EDGAR
2023-11-214Allovir, Inc. (ALVR)Sale (S): 403 @ $1.63EDGAR
2023-10-234Allovir, Inc. (ALVR)Sale (S): 358 @ $1.58 · Sale (S): 357 @ $1.54EDGAR
2023-10-054Allovir, Inc. (ALVR)Sale (S): 222 @ $1.98EDGAR
2023-08-214Allovir, Inc. (ALVR)Sale (S): 1,653 @ $2.50EDGAR
2023-07-214Allovir, Inc. (ALVR)Sale (S): 342 @ $3.56 · Sale (S): 342 @ $3.35EDGAR
2023-06-134Allovir, Inc. (ALVR)Sale (S): 5,045 @ $5.64EDGAR
2023-04-214Allovir, Inc. (ALVR)Sale (S): 348 @ $3.71 · Sale (S): 349 @ $3.63EDGAR
2023-02-034Allovir, Inc. (ALVR)Grant/award (A): 61,250 @ $0 · Grant/award (A): 113,750 (derivative) @ $0EDGAR
2023-01-234Allovir, Inc. (ALVR)Sale (S): 1,557 @ $5.08 · Sale (S): 338 @ $5.14EDGAR
2022-11-144Allovir, Inc. (ALVR)Sale (S): 5,989 @ $8.00 · Sale (S): 18,011 @ $8.18EDGAR
2022-10-264/AAllovir, Inc. (ALVR)Sale (S): 345 @ $9.36EDGAR
2022-10-244Allovir, Inc. (ALVR)Sale (S): 345 @ $9.36 · Sale (S): 11,334 @ $8.45 · Sale (S): 2,000 @ $8.13EDGAR
2022-08-174Allovir, Inc. (ALVR)Grant/award (A): 20,000 @ $0EDGAR
2022-07-064Allovir, Inc. (ALVR)Grant/award (A): 10,500 @ $0 · Grant/award (A): 19,500 (derivative) @ $0EDGAR
2022-04-224Allovir, Inc. (ALVR)Sale (S): 276 @ $6.68EDGAR
2022-04-044Allovir, Inc. (ALVR)Grant/award (A): 17,442 @ $0 · Grant/award (A): 42,558 (derivative) @ $0EDGAR
2022-01-244Allovir, Inc. (ALVR)Sale (S): 1,563 @ $8.75EDGAR
2021-02-234Allovir, Inc. (ALVR)Sale (S): 800 @ $43.14EDGAR
2021-02-194Allovir, Inc. (ALVR)Sale (S): 200 @ $39.35 · Sale (S): 541 @ $40.39EDGAR
2021-02-184Allovir, Inc. (ALVR)Sale (S): 2,750 @ $41.82 · Sale (S): 300 @ $42.67 · Sale (S): 600 @ $38.56 · Sale (S): 220 @ $39.86 · Sale (S): 1,300 @ $41.17 · Sale (S): 200 @ $41.68EDGAR
2021-01-214Allovir, Inc. (ALVR)Grant/award (A): 17,500 @ $0 · Grant/award (A): 32,500 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-11-20 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1681782 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs